• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

    4/19/24 5:45:48 AM ET
    $ADPT
    $AGBA
    $BGLC
    $BPTH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Investment Managers
    Finance
    Get the next $ADPT alert in real time by email

    Shares of Wang & Lee Group, Inc. (NASDAQ:WLGS) rose sharply in today's pre-market trading after the company reported a year-over-year increase in FY23 financial results.

    Wang & Lee Group posted a FY23 loss of 2 cents per share, versus a year-ago loss of 5 cents per share. The company's revenue came in at $6.83 million versus, $4.17 million in the year-ago period, according to data from Benzinga Pro.

    Wang & Lee Group shares jumped 37.7% to $0.7220 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Redwoods Acquisition Corp. (NASDAQ:RWOD) shares gained 141% to $17.83 in pre-market trading after falling around 3% on Thursday.
    • Zhongchao Inc. (NASDAQ:ZCMD) gained 75.6% to $2.53 in pre-market trading after gaining over 7% on Thursday.
    • Trio Petroleum Corp. (NYSE:TPET) gained 30% to $0.4261 in pre-market trading. The company on Wednesday announced it entered into a securities purchase agreement with an institutional investor in the amount of $360,000.
    • HUB Cyber Security Ltd. (NASDAQ:HUBC) shares rose 24.7% to $1.61 in pre-market trading after falling 4% on Thursday.
    • SuperCom Ltd. (NASDAQ:SPCB) gained 22% to $0.2927 in pre-market trading. SuperCom shares fell around 33% on Thursday after the company priced a $2.9 million registered direct offering.
    • Bio-Path Holdings, Inc. (NASDAQ:BPTH) rose 19.3% to $5.01 in today's pre-market trading after jumping 30% on Thursday. Bio-Path announced a $1.2 million registered direct offering priced at-the-market under Nasdaq rules.
    • Centogene N.V. (NASDAQ:CNTG) shares gained 19.3% to $0.5513 in pre-market trading.
    • Kineta, Inc. (NASDAQ:KA) rose 14.7% to $0.5601 in pre-market trading. Kineta was recently granted a US patent titled ‘Proteasome activity enhancing compounds (including methods for treating cancer or tumors).’
    • Paramount Global (NASDAQ:PARA) shares gained 10.5% to $12.12 in pre-market trading. Apollo Global Management and Sony Group Corp. are reportedly in talks on a joint offer for Paramount Global.

    Losers

    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) fell 22.4% to $0.66 in pre-market trading after jumping around 29% on Thursday. BioNexus Gene Lab agreed to invest RM 1.2 million in Ascension Innovation (AISB) to advance digital health innovation through AI adoption in healthcare.
    • Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) fell 19.9% to $0.6407 in pre-market trading after surging 65% on Thursday.
    • iSpecimen Inc. (NASDAQ:ISPC) fell 19.3% to $0.3396 in pre-market trading after gaining around 98% on Thursday.
    • AGBA Group Holding Limited (NASDAQ:AGBA) fell 13.6% to $0.89 in pre-market trading. AGBA Group Holding shares jumped 155% on Thursday higher after the company announced it entered into a definitive merger agreement with Triller.
    • Spectaire Holdings Inc. (NASDAQ:SPEC) declined 12.3% to $0.5426 in pre-market trading after falling over 20% on Thursday. Spectaire Holdings recently signed a distribution partnership agreement with a Fortune 1000 Energy Company.
    • Lantern Pharma Inc. (NASDAQ:LTRN) shares fell 12.1% to $5.07 in pre-market trading.
    • Adaptive Biotechnologies Corporation (NASDAQ:ADPT) shares declined 11.4% to $2.07 in pre-market trading. Adaptive Biotechnologies is expected to report financial results for the first quarter 2024 after the closing bell on May 7, 2024.
    • Soligenix, Inc. (NASDAQ:SNGX) shares fell 11.1% to $0.3870 in pre-market trading. Soligenix shares fell around 15% on Thursday after the company announced the pricing of a $4.75 million public offering.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) fell 10.2% to $2.65 pre-market trading after jumping around 32% on Thursday.
    • Netflix, Inc. (NASDAQ:NFLX) fell 6% to $573.81 pre-market trading. Netflix reported upbeat earnings and sales results for its first quarter. The company added 9.33 million paid net new subscribers in the first quarter to bring the company to a total of 269.60 million.

    Read More: Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Friday

    Get the next $ADPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADPT
    $AGBA
    $BGLC
    $BPTH

    CompanyDatePrice TargetRatingAnalyst
    Netflix Inc.
    $NFLX
    4/20/2026$115.00 → $110.00Outperform
    Bernstein
    Netflix Inc.
    $NFLX
    4/6/2026$120.00Neutral → Buy
    Goldman
    Netflix Inc.
    $NFLX
    3/30/2026Mkt Perform
    Citizens
    Netflix Inc.
    $NFLX
    3/24/2026Hold → Buy
    Erste Group
    Netflix Inc.
    $NFLX
    3/18/2026$115.00Buy
    Citigroup
    Netflix Inc.
    $NFLX
    3/9/2026$105.00Equal Weight
    Wells Fargo
    Netflix Inc.
    $NFLX
    3/2/2026$115.00Equal Weight
    Barclays
    Netflix Inc.
    $NFLX
    3/2/2026$120.00Overweight
    Analyst
    More analyst ratings

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bernstein reiterated coverage on Netflix with a new price target

    Bernstein reiterated coverage of Netflix with a rating of Outperform and set a new price target of $110.00 from $115.00 previously

    4/20/26 9:37:22 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Netflix upgraded by Goldman with a new price target

    Goldman upgraded Netflix from Neutral to Buy and set a new price target of $120.00

    4/6/26 8:40:42 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Citizens initiated coverage on Netflix

    Citizens initiated coverage of Netflix with a rating of Mkt Perform

    3/30/26 8:19:42 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and COO Rubinstein Julie exercised 44,166 shares at a strike of $8.46 and sold $798,423 worth of shares (57,180 units at $13.96) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 382,132 units (SEC Form 4)

    4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)

    4/24/26 6:29:47 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Rubinstein Julie

    4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)

    4/21/26 6:07:41 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Trabelsi Barak

    3 - SuperCom Ltd (0001291855) (Issuer)

    4/20/26 5:30:18 PM ET
    $SPCB
    Semiconductors
    Technology

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    SEC Filings

    View All

    SEC Form DEFA14A filed by Adaptive Biotechnologies Corporation

    DEFA14A - Adaptive Biotechnologies Corp (0001478320) (Filer)

    4/24/26 4:31:02 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by Adaptive Biotechnologies Corporation

    DEF 14A - Adaptive Biotechnologies Corp (0001478320) (Filer)

    4/24/26 4:30:23 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Netflix Inc. filed SEC Form 8-K: Other Events

    8-K - NETFLIX INC (0001065280) (Filer)

    4/22/26 7:13:24 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHAIRMAN, CEO AND PRESIDENT Schaber Christopher J bought $20,000 worth of shares (15,132 units at $1.32), increasing direct ownership by 3,993% to 15,511 units (SEC Form 4)

    4 - SOLIGENIX, INC. (0000812796) (Issuer)

    10/3/25 1:18:09 PM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lantern Pharma to Debut Public Demonstration of withZeta.ai - A Platform to Conquer Rare Cancers on April 30 Following AACR 2026 Scientific Debut

    CEO Panna Sharma to Lead Live, Unscripted Platform Walkthrough in Two Interactive Sessions on April 30, 2026 — Open to Investors, Researchers, and the Global Biomedical Community Registration Link & Details Can be Accessed Below Lantern Pharma Inc. (NASDAQ:LTRN) ("Lantern" or the "Company"), an AI-driven clinical-stage precision oncology company, today announced the first public demonstration of withZeta.ai, its multi-agentic AI co-scientist platform, to be held on Thursday, April 30, 2026. The event follows the platform's scientific community debut at the American Association for Cancer Research (AACR) Annual Meeting 2026 and its initial unveiling at Nasdaq MarketSite — and marks th

    4/24/26 7:50:00 AM ET
    $LTRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    MicroCloud Hologram Inc. launches research and development plan for Bitcoin quantum-resistant protocol.

    SHENZHEN, China, April 22, 2026 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ:HOLO), ("HOLO" or the "Company"), a technology service provider, announces its participation in the research and development of a Bitcoin quantum-resistant protocol. The company plans to introduce a forward-looking, progressively upgradable post-quantum security protocol system. This move not only signifies the company's strategic positioning in the field of quantum security but also signals that blockchain technology is entering a critical phase of post-quantum defense. MicroCloud Hologram Inc. announces its participation in the design and implementation of a new generation Bitcoin quantum-resistant protocol. T

    4/22/26 10:15:00 AM ET
    $HOLO
    Computer Software: Programming Data Processing
    Technology

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 5, 2021 - Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test

    For Immediate Release: March 05, 2021 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the T-Detect COVID Test developed by Adaptive Biotechnologies. The T-Detect COVID Test is a next generation sequencing based (NGS) test to aid in identifying individuals with an adaptive T cell immune response to SARS-CoV-2, indicating recent or prior infection with SARS-CoV-2.  “Today’s authorization further und

    3/5/21 10:37:33 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    Financials

    Live finance-specific insights

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026

    SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2026 after market close on Tuesday, May 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the "Investors" section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours a

    4/15/26 4:05:00 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

    Year of Clinical Validation and Strategic Expansion Across Pipeline, AI Platform Advances Towards Commercialization, and Global Trial Milestones LP-300 Phase 2 HARMONIC™ Trial Progress: Continued enrollment and patient follow-up across the United States, Japan, and Taiwan. Completion of targeted enrollment in Japan across five clinical sites including the National Cancer Center Tokyo. Preliminary data presented at the 66th Annual Meeting of the Japan Lung Cancer Society. Type C meeting package submitted to FDA in March 2026, with meeting scheduled for mid-May 2026 seeking feedback on proposed protocol amendments including focusing enrollment on EGFR exon 21 L858R patients and updating th

    3/30/26 4:05:00 PM ET
    $LTRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    Leadership Updates

    Live Leadership Updates

    View All

    HUB Cyber Security Announces Leadership Transition

    TEL AVIV, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ:HUBC) ("HUB" or the "Company"), announced that Noah Hershcoviz has resigned from his position as Chief Executive Officer and as a member of the Company's Board of Directors (the "Board"), effective immediately. Renah Persofsky, the Active Chairperson of the Board, will take on a greater role in the management of the Company, while the Company seeks to find a suitable interim replacement for Mr. Hershcoviz, which it hopes to announce shortly. The Company intends to commence a search for qualified candidates to serve as a new permanent CEO in the coming days.       "The Board of Directors appreciates Noah's

    3/31/26 4:30:00 PM ET
    $HUBC
    Computer Communications Equipment
    Telecommunications

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    HUB Cyber Security Appoints Limor Zur-Stoller as Chief Financial Officer

    TEL AVIV, Israel, Jan. 12, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ:HUBC) ("HUB" or the "Company"), a global provider of confidential computing, secured data fabric, and regulated AI trust infrastructure, today announced the appointment of Limor Zur‑Stoller as Chief Financial Officer, effective immediately. Ms. Zur-Stoller brings more than 20 years of senior financial leadership experience across public and private companies, including Nasdaq and TASE listed organizations, high growth technology ventures, and complex global operating environments. Her expertise spans capital markets execution, IPOs, fundraising, mergers and acquisitions, post-merger integration, and financ

    1/12/26 10:04:25 AM ET
    $HUBC
    Computer Communications Equipment
    Telecommunications

    $ADPT
    $AGBA
    $BGLC
    $BPTH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Trio Petroleum Corp.

    SC 13G - Trio Petroleum Corp. (0001898766) (Subject)

    11/14/24 5:34:32 PM ET
    $TPET
    Oil & Gas Production
    Energy

    Amendment: SEC Form SC 13G/A filed by Spectaire Holdings Inc.

    SC 13G/A - Spectaire Holdings Inc. (0001844149) (Subject)

    11/14/24 1:45:01 PM ET
    $SPEC
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Adaptive Biotechnologies Corporation

    SC 13G - Adaptive Biotechnologies Corp (0001478320) (Subject)

    11/13/24 4:30:24 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care